Literature DB >> 10070584

Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark.

L B Jensen, A M Hammerum, R L Poulsen, H Westh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10070584      PMCID： PMC89195     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  20 in total

1.  Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs, and poultry.

Authors:  L B Jensen
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

2.  Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms.

Authors:  F M Aarestrup
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

Review 3.  Resistance to glycopeptides in enterococci.

Authors:  R Leclercq; P Courvalin
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

4.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

5.  Presence of vancomycin-resistant enterococci in farm and pet animals.

Authors:  L A Devriese; M Ieven; H Goossens; P Vandamme; B Pot; J Hommez; F Haesebrouck
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

6.  Characterization of antimicrobial resistance in enterococci of animal origin.

Authors:  L A Thal; J W Chow; R Mahayni; H Bonilla; M B Perri; S A Donabedian; J Silverman; S Taber; M J Zervos
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

7.  Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.

Authors:  T M Coque; J F Tomayko; S C Ricke; P C Okhyusen; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

8.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

9.  Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster.

Authors:  F M Aarestrup; P Ahrens; M Madsen; L V Pallesen; R L Poulsen; H Westh
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  vanA-mediated vancomycin-resistant Enterococcus spp. in sewage.

Authors:  C Torres; J A Reguera; M J Sanmartin; J C Pérez-Díaz; F Baquero
Journal:  J Antimicrob Chemother       Date:  1994-03       Impact factor: 5.790
View more
  10 in total

1.  Identification of a Tn1546-like (type 2) element in vancomycin-resistant Enterococcus faecium isolated from hospitalized patients in Japan.

Authors:  R Kariyama; H Kuman; A M Hammerum; F M Aarestrup; L B Jensen
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Relationship between copper, glycopeptide, and macrolide resistance among Enterococcus faecium strains isolated from pigs in Denmark between 1997 and 2003.

Authors:  Henrik Hasman; Frank M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Enterococcus faecium-related outbreak with molecular evidence of transmission from pigs to humans.

Authors:  Hong-Zhou Lu; Xin-Hua Weng; Haijing Li; You-Kuan Yin; Mao-Yin Pang; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Characterization of vancomycin-resistant Enterococcus faecium isolated from swine in three Michigan counties.

Authors:  Susan M Donabedian; Mary Beth Perri; Nodira Abdujamilova; Mary Joy Gordoncillo; Amir Naqvi; Katherine C Reyes; Marcus J Zervos; Paul Bartlett
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

5.  Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins.

Authors:  P R Descheemaeker; S Chapelle; L A Devriese; P Butaye; P Vandamme; H Goossens
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Human and swine hosts share vancomycin-resistant Enterococcus faecium CC17 and CC5 and Enterococcus faecalis CC2 clonal clusters harboring Tn1546 on indistinguishable plasmids.

Authors:  Ana R Freitas; Teresa M Coque; Carla Novais; Anette M Hammerum; Camilla H Lester; Marcus J Zervos; Susan Donabedian; Lars B Jensen; Maria Victoria Francia; Fernando Baquero; Luísa Peixe
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

7.  Quinupristin-dalfopristin resistance in Enterococcus faecium isolates from humans, farm animals, and grocery store meat in the United States.

Authors:  S M Donabedian; M B Perri; D Vager; E Hershberger; P Malani; S Simjee; J Chow; E N Vergis; R R Muder; K Gay; F J Angulo; P Bartlett; M J Zervos
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 8.  A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant Enterococci isolated in New Zealand.

Authors:  Janet M Manson; Stefanie Keis; John M B Smith; Gregory M Cook
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 9.  Antibiotics in agriculture and the risk to human health: how worried should we be?

Authors:  Qiuzhi Chang; Weike Wang; Gili Regev-Yochay; Marc Lipsitch; William P Hanage
Journal:  Evol Appl       Date:  2014-08-02       Impact factor: 5.183

Review 10.  Genomic interplay in bacterial communities: implications for growth promoting practices in animal husbandry.

Authors:  Piklu Roy Chowdhury; Jessica McKinnon; Ethan Wyrsch; Jeffrey M Hammond; Ian G Charles; Steven P Djordjevic
Journal:  Front Microbiol       Date:  2014-08-12       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.